Literature DB >> 31599484

Management of coexistent neurogenic orthostatic hypotension and supine hypertension.

David S Cannom1.   

Abstract

Entities:  

Keywords:  blood pressure; droxidopa; midodrine; neurogenic orthostatic hypotension; supine hypertension

Mesh:

Substances:

Year:  2019        PMID: 31599484      PMCID: PMC8030279          DOI: 10.1111/jch.13699

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

1.  Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension.

Authors:  P Sandroni; E E Benarroch; E F Wijdicks
Journal:  Mayo Clin Proc       Date:  2001-12       Impact factor: 7.616

2.  Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?

Authors:  Aristide Merola; Alberto Romagnolo; Michela Rosso; José Ricardo Lopez-Castellanos; Benjamin D Wissel; Sydney Larkin; Andrea Bernardini; Maurizio Zibetti; Simona Maule; Leonardo Lopiano; Alberto J Espay
Journal:  Parkinsonism Relat Disord       Date:  2016-09-10       Impact factor: 4.891

3.  Renal impairment of pure autonomic failure.

Authors:  Emily M Garland; Alfredo Gamboa; Luis Okamoto; Satish R Raj; Bonnie K Black; Thomas L Davis; Italo Biaggioni; David Robertson
Journal:  Hypertension       Date:  2009-09-08       Impact factor: 10.190

4.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

Authors:  P A Low; J L Gilden; R Freeman; K N Sheng; M A McElligott
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

5.  Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease.

Authors:  Clement François; Italo Biaggioni; Cyndya Shibao; Augustina Ogbonnaya; Huai-Che Shih; Eileen Farrelly; Adam Ziemann; Amy Duhig
Journal:  J Med Econ       Date:  2017-02-06       Impact factor: 2.448

6.  Orthostatic hypotension in Parkinson disease: Impact on health care utilization.

Authors:  Aristide Merola; Russell P Sawyer; Carlo Alberto Artusi; Ritika Suri; Zoe Berndt; Jose' Ricardo Lopez-Castellanos; Jennifer Vaughan; Joaquin A Vizcarra; Alberto Romagnolo; Alberto J Espay
Journal:  Parkinsonism Relat Disord       Date:  2017-11-28       Impact factor: 4.891

7.  Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

Authors:  Italo Biaggioni; L Arthur Hewitt; Gerald J Rowse; Horacio Kaufmann
Journal:  BMC Neurol       Date:  2017-05-12       Impact factor: 2.474

8.  Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension.

Authors:  Clément François; Cyndya A Shibao; Italo Biaggioni; Amy M Duhig; Kim McLeod; Augustina Ogbonnaya; Apryl Quillen; Joan Cannon; Byron Padilla; Binglin Yue; Laurie Orloski; Steven M Kymes
Journal:  Mov Disord Clin Pract       Date:  2019-03-07

9.  Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers.

Authors:  Daniel O Claassen; Charles H Adler; L Arthur Hewitt; Christopher Gibbons
Journal:  BMC Neurol       Date:  2018-08-25       Impact factor: 2.474

Review 10.  Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH).

Authors:  Alessandra Fanciulli; Jens Jordan; Italo Biaggioni; Giovanna Calandra-Buonaura; William P Cheshire; Pietro Cortelli; Sabine Eschlboeck; Guido Grassi; Max J Hilz; Horacio Kaufmann; Heinz Lahrmann; Giuseppe Mancia; Gert Mayer; Lucy Norcliffe-Kaufmann; Anne Pavy-Le Traon; Satish R Raj; David Robertson; Isabel Rocha; Walter Struhal; Roland Thijs; Konstantinos P Tsioufis; J Gert van Dijk; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2018-05-15       Impact factor: 4.435

View more
  1 in total

1.  Management of coexistent neurogenic orthostatic hypotension and supine hypertension.

Authors:  David S Cannom
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-10       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.